Published in Maturitas on December 03, 2011
Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol (2014) 1.19
The link between chronic kidney disease and cardiovascular disease. J Nephropathol (2014) 1.11
Diabetes and risk of cancer. ISRN Oncol (2013) 1.06
Factors associated with quality of life among hemodialysis patients in Malaysia. PLoS One (2013) 0.90
Hypoglycemia in Patients with Diabetes and Renal Disease. J Clin Med (2015) 0.83
Association of metabolic syndrome with decreased glomerular filtration rate among 75,468 Chinese adults: a cross-sectional study. PLoS One (2014) 0.80
Role of Superoxide Dismutase 2 Gene Ala16Val Polymorphism and Total Antioxidant Capacity in Diabetes and its Complications. Avicenna J Med Biotechnol (2016) 0.79
The impact of blood pressure on kidney function in the elderly: a cross-sectional study. Kidney Blood Press Res (2014) 0.79
Prevalence of chronic kidney disease across levels of glycemia among adults in Pudong New Area, Shanghai, China. BMC Nephrol (2013) 0.79
Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES 2007-2012. BMJ Open Diabetes Res Care (2016) 0.77
Fluctuation between fasting and 2-H postload glucose state is associated with chronic kidney disease in previously diagnosed type 2 diabetes patients with HbA1c ≥ 7%. PLoS One (2014) 0.76
Influence of vanadium-organic ligands treatment on selected metal levels in kidneys of STZ rats. Biol Trace Elem Res (2013) 0.75
STORE OPERATED CALCIUM ENTRY SUPPRESSED TGFβ1-SMAD3 SIGNALING PATHWAY IN GLOMERULAR MESANGIAL CELLS. Am J Physiol Renal Physiol (2017) 0.75
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet (2010) 9.20
Point: visceral adiposity is causally related to insulin resistance. Diabetes Care (2005) 2.81
Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care (2010) 2.15
Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J Clin Psychiatry (2004) 1.41
Early-life stress and the development of obesity and insulin resistance in juvenile bonnet macaques. Diabetes (2007) 1.17
Type 2 diabetes in South Asians: a pathophysiologic focus on the Asian-Indian epidemic. Curr Diab Rep (2004) 1.14
The role of complementary and alternative medicine in diabetes. Curr Diab Rep (2006) 1.13
Management of type 2 diabetes in treatment-naive elderly patients: benefits and risks of vildagliptin monotherapy. Diabetes Care (2007) 1.12
Autoantibodies in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab (2002) 1.03
Treatment of insulin resistance in diabetes mellitus. Eur J Pharmacol (2004) 1.02
Diabetes and female sexual dysfunction: moving beyond "benign neglect". Curr Diab Rep (2005) 0.87
Non-insulin injectable treatments (glucagon-like peptide-1 and its analogs) and cardiovascular disease. Diabetes Technol Ther (2012) 0.83
High-dose atorvastatin after stroke or transient ischemic attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. J Cardiometab Syndr (2008) 0.81
Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity. J Pediatr Endocrinol Metab (2004) 0.80
Hypopituitarism in the elderly. Maturitas (2012) 0.79
Efficacy and risk of hypoglycemia with use of insulin glargine or comparators in patients with cardiovascular risk factors. Postgrad Med (2014) 0.78
Type 2 diabetes mellitus in African-American adolescents: impaired beta-cell function in the face of severe insulin resistance. J Pediatr Endocrinol Metab (2006) 0.77
Cardiovascular disease in adolescents with type 2 diabetes mellitus. J Pediatr Endocrinol Metab (2002) 0.76
Utilizing current diagnostic criteria and treatment algorithms for managing type 2 diabetes mellitus. Postgrad Med (2011) 0.76
Metabolic syndrome and neurometabolic asymmetry of hippocampus in adult bonnet monkeys. Physiol Behav (2011) 0.76
Chronobiology impacts response to antihypertensive drug regimen in type 2 diabetes. Diabetes Care (2011) 0.75
Corticotropin releasing factor (CRF) and obesity. Maturitas (2012) 0.75
What are the long-term cardiovascular effects of treatment with rosiglitazone? Curr Diab Rep (2008) 0.75
Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab (2002) 0.75
Improving outcomes in patients with acute coronary syndromes. Curr Diab Rep (2004) 0.75
Reducing mortality in critically ill patients. Curr Diab Rep (2004) 0.75
Rimonabant--the RIO North America trial: a new strategy to sustaining weight loss and related morbidity. Curr Diab Rep (2006) 0.75
Diabetes and bone health. Maturitas (2013) 0.75
Intensive insulin therapy: is it effective in the medical intensive care unit? Curr Diab Rep (2006) 0.75